Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial.
Spadera L, Lugarà M, Spadera M, Conticelli M, Oliva G, Bassi V, Apuzzi V, Calderaro F, Fattoruso O, Guzzi P, D'Amora M, Catapano O, Marra R, Galdo M, Zappalà M, Inui T, Mette M, Vitiello G, Corvino M, Tortoriello G.
Spadera L, et al. Among authors: calderaro f.
Biomed Pharmacother. 2023 Dec 31;169:115894. doi: 10.1016/j.biopha.2023.115894. Epub 2023 Nov 21.
Biomed Pharmacother. 2023.
PMID: 37988850
Free article.
Clinical Trial.